Retatrutide 30mg Synbio Pen | Research Peptide | EU Manufactured

Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide agonist that simultaneously activates three key metabolic receptors: GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor). This triple-agonist profile makes it one of the most studied next-generation metabolic peptides in current preclinical and clinical research.

The Synbio Pen format (30mg) is designed for extended research protocols and multi-experiment workflows, offering a convenient, pre-loaded delivery format suitable for controlled laboratory environments.

Research Applications Investigators are currently studying Retatrutide across multiple areas, including:

• Metabolic regulation and energy expenditure modelling
• Glycemic control and insulin signalling pathways
• Obesity and body composition research
• Liver metabolism and NAFLD/NASH endpoint studies
• Cardiometabolic risk marker investigations

Quality & Sourcing Manufactured within the EU under controlled synthesis conditions. Each batch is HPLC-verified to ≥99% purity and accompanied by a full Certificate of Analysis (COA) for traceability and reproducibility. Tamper-evident packaging supports laboratory intake SOPs.

For Research Use Only. Not for human or animal consumption. Not approved for therapeutic, diagnostic, or veterinary use. By purchasing, the buyer confirms use is restricted to qualified professionals in lawful scientific research contexts.